Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

Authors: Emmanuel Mignot, David Mayleben, Ingo Fietze, Damien Léger, Gary Zammit, Claudio L. Bassetti, Scott Pain, Dalma Seboek Kinter, Thomas Roth - The Lancet 2022 cited by 234